Skip to main content

Drug Interactions between fluconazole and nitrofurantoin

This report displays the potential drug interactions for the following 2 drugs:

Edit list (add/remove drugs)

Interactions between your drugs

Moderate

fluconazole nitrofurantoin

Applies to: fluconazole and nitrofurantoin

MONITOR: The concomitant administration of nitrofurantoin and fluconazole may increase the risk of hepatic and pulmonary toxicity. The mechanism is unknown. A 73-year-old patient who had been taking nitrofurantoin for 5 years developed respiratory symptoms (fatigue, dyspnea, cough, pleuritic pain, and tracheal pain) and hepatic enzyme elevations 2 months after fluconazole 150 mg/week was added to his regimen. A diagnosis of pulmonary fibrosis was made after chest X-rays and respiratory tests were performed. The patient also took multiple other drugs including terazosin, cimetidine, fluticasone nasal spray, diphenhydramine, ibuprofen, fluocinonide ointment, multivitamin, vitamin E, calcium-vitamin D, aspirin, calcium polycarbophil, and docusate, and drank moderate amounts of alcohol. Symptoms improved gradually after discontinuation of nitrofurantoin and fluconazole. Nitrofurantoin alone is known to cause pulmonary toxicity (usually pulmonary fibrosis or interstitial pneumonitis) and both drugs individually have been associated with hepatic toxicity.

MANAGEMENT: Until more information is available it may be advisable to monitor patients for signs of adverse pulmonary and hepatic effects during concomitant administration. Patients should be advised to notify their physician if they develop cough, dyspnea, fatigue, or pain.

References (1)
  1. Linnebur SA, Parnes BL (2004) "Pulmonary and hepatic toxicity due to nitrofurantoin and fluconazole treatment." Ann Pharmacother, 38, p. 612-6

Drug and food interactions

No alcohol/food interactions were found. However, this does not necessarily mean no interactions exist. Always consult your healthcare provider.

Therapeutic duplication warnings

No warnings were found for your selected drugs.

Therapeutic duplication warnings are only returned when drugs within the same group exceed the recommended therapeutic duplication maximum.


Report options

Drug Interaction Classification

These classifications are only a guideline. The relevance of a particular drug interaction to a specific individual is difficult to determine. Always consult your healthcare provider before starting or stopping any medication.
Major Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit.
Moderate Moderately clinically significant. Usually avoid combinations; use it only under special circumstances.
Minor Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan.
Unknown No interaction information available.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.